Cargando…

Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %

INTRODUCTION: Equine superficial digital flexor tendon injury is a well-accepted model of human tendon injury and is routinely treated with local injections of autologous mesenchymal stem cells (MSCs). Identification of a clinically safe medium for short-term cryopreservation of MSCs prior to cell i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Alexis, Rivas, Kristen A., Smith, Roger, Watts, Ashlee E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661990/
https://www.ncbi.nlm.nih.gov/pubmed/26611913
http://dx.doi.org/10.1186/s13287-015-0230-y
_version_ 1782403091974324224
author Mitchell, Alexis
Rivas, Kristen A.
Smith, Roger
Watts, Ashlee E.
author_facet Mitchell, Alexis
Rivas, Kristen A.
Smith, Roger
Watts, Ashlee E.
author_sort Mitchell, Alexis
collection PubMed
description INTRODUCTION: Equine superficial digital flexor tendon injury is a well-accepted model of human tendon injury and is routinely treated with local injections of autologous mesenchymal stem cells (MSCs). Identification of a clinically safe medium for short-term cryopreservation of MSCs prior to cell implantation would streamline laboratory and clinical procedures for autologous regenerative therapies. Veterinary experience with short-term (MSCs prepared after the injury has occurred) cryopreserved MSCs in naturally occurring injury in the horse will be of value to human practitioners. METHODS: Equine bone marrow derived MSCs were cryopreserved in 6 different solutions consisting of 20 % serum, 10 % DMSO and 70 % media or 95 % serum and 5 % DMSO. Serum was autologous serum, commercially available pooled equine serum or fetal bovine serum (FBS). Cell survival, morphology and growth kinetics were assessed by total cell number, measurement of growth kinetics, colony-forming-unit-assay and morphology of MSCs after monolayer culture post-thaw. RESULTS: There were no significant differences in post-thaw viability, total cell number, morphology scores or growth kinetics among the 6 solutions. Post thaw viabilities from each group ranged from 80-90 %. In all solutions, there were significantly fewer MSCs and the majority (99 %) of MSCs remained in the original generation 24 hours post-thaw. Seventy two hours post-thaw, the majority of MSCs (50 %) were proliferating in the fourth generation. Mean colony count in the CFU-F assay ranged from 72 to 115 colonies. CONCLUSIONS: Each of the serum sources could be used for short-term cryopreservation of equine bone marrow derived MSCs. Prior to clinical use, clinicians may prefer autologous serum and a lower concentration of DMSO. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-015-0230-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4661990
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46619902015-11-28 Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 % Mitchell, Alexis Rivas, Kristen A. Smith, Roger Watts, Ashlee E. Stem Cell Res Ther Research INTRODUCTION: Equine superficial digital flexor tendon injury is a well-accepted model of human tendon injury and is routinely treated with local injections of autologous mesenchymal stem cells (MSCs). Identification of a clinically safe medium for short-term cryopreservation of MSCs prior to cell implantation would streamline laboratory and clinical procedures for autologous regenerative therapies. Veterinary experience with short-term (MSCs prepared after the injury has occurred) cryopreserved MSCs in naturally occurring injury in the horse will be of value to human practitioners. METHODS: Equine bone marrow derived MSCs were cryopreserved in 6 different solutions consisting of 20 % serum, 10 % DMSO and 70 % media or 95 % serum and 5 % DMSO. Serum was autologous serum, commercially available pooled equine serum or fetal bovine serum (FBS). Cell survival, morphology and growth kinetics were assessed by total cell number, measurement of growth kinetics, colony-forming-unit-assay and morphology of MSCs after monolayer culture post-thaw. RESULTS: There were no significant differences in post-thaw viability, total cell number, morphology scores or growth kinetics among the 6 solutions. Post thaw viabilities from each group ranged from 80-90 %. In all solutions, there were significantly fewer MSCs and the majority (99 %) of MSCs remained in the original generation 24 hours post-thaw. Seventy two hours post-thaw, the majority of MSCs (50 %) were proliferating in the fourth generation. Mean colony count in the CFU-F assay ranged from 72 to 115 colonies. CONCLUSIONS: Each of the serum sources could be used for short-term cryopreservation of equine bone marrow derived MSCs. Prior to clinical use, clinicians may prefer autologous serum and a lower concentration of DMSO. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13287-015-0230-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-26 /pmc/articles/PMC4661990/ /pubmed/26611913 http://dx.doi.org/10.1186/s13287-015-0230-y Text en © Mitchell et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mitchell, Alexis
Rivas, Kristen A.
Smith, Roger
Watts, Ashlee E.
Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %
title Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %
title_full Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %
title_fullStr Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %
title_full_unstemmed Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %
title_short Cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and DMSO at 10 or 5 %
title_sort cryopreservation of equine mesenchymal stem cells in 95 % autologous serum and 5 % dmso does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95 % and dmso at 10 or 5 %
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661990/
https://www.ncbi.nlm.nih.gov/pubmed/26611913
http://dx.doi.org/10.1186/s13287-015-0230-y
work_keys_str_mv AT mitchellalexis cryopreservationofequinemesenchymalstemcellsin95autologousserumand5dmsodoesnotalterpostthawgrowthormorphologyinvitrocomparedtofetalbovineserumorallogeneicserumat20or95anddmsoat10or5
AT rivaskristena cryopreservationofequinemesenchymalstemcellsin95autologousserumand5dmsodoesnotalterpostthawgrowthormorphologyinvitrocomparedtofetalbovineserumorallogeneicserumat20or95anddmsoat10or5
AT smithroger cryopreservationofequinemesenchymalstemcellsin95autologousserumand5dmsodoesnotalterpostthawgrowthormorphologyinvitrocomparedtofetalbovineserumorallogeneicserumat20or95anddmsoat10or5
AT wattsashleee cryopreservationofequinemesenchymalstemcellsin95autologousserumand5dmsodoesnotalterpostthawgrowthormorphologyinvitrocomparedtofetalbovineserumorallogeneicserumat20or95anddmsoat10or5